Remdesivir is used to treat Covid-19
For people who were hospitalized with Covid-19 and had indications of lower respiratory tract infection, we conducted a double-blind, randomized, placebo-controlled study with intravenous remdesivir. For up to 10 days, patients were randomly randomized to receive either remdesivir (200 mg loading dose on day 1, then 100 mg daily for up to 9 days) or…
Reach us on WhatsApp